Global infrastructure fund manager Morrison has invested in Fillex, a newly launched US pharmacy logistics platform.
Morrison’s investment is being made via its global middle-market vehicle, Morrison Value Add II (MVA II), which seeks capital growth by investing in high-potential global opportunities.
The investment amount remains undisclosed.
Fillex, led by CEO Dain Rusk, who most recently served as VP of pharmacy for Publix, provides centralised, automated pharmacy fulfillment services to retail pharmacies, grocery chains, e-commerce providers and health systems nationally.
Prior to joining Publix, Rusk served as the group VP of pharmacy operations at the Albertsons Companies.
Morrison operating partner Marvin Richardson, will be joining Fillex’s board of directors as chair.
Rusk said: “Our mission at Fillex is to transform prescription fulfillment to ensure essential community care is available on every corner by reducing the operational and capital burden on pharmacy providers.
“This enables them to run more efficiently while reclaiming essential time for patient care and improving clinical outcomes.”
Richardson said: “Fillex provides the missing infrastructure layer for modern pharmacy — an open-access platform that allows operators to scale, protect margins, and remain focused on patient care.”
William Smales, CIO at Morrison, said: “Since 1988, Morrison has been building infrastructure businesses that meet evolving societal needs both in the US and globally. While AI-powered automation has the potential to revolutionise pharmacy fulfillment, these next-generation capabilities have remained out of reach for most because they lack the capital, operating scale, and technical capability required to build and manage such complex infrastructure.
“The launch of Fillex bridges this critical gap by leveraging Morrison’s deep in-house expertise and our long-standing track record of investing in essential infrastructure.”
Perry Offutt, Morrison’s New York-based co-head of MVA II, said, “We are very excited to bring this powerful ‘idea that matters’ to market for the benefit of pharmacies, customers, and our investors.
“This investment by MVA II underscores the need for infrastructure capital to provide high-quality logistics and fulfillment facilities, drive new efficiency gains, and expand the capacity and resiliency of the entire healthcare system.”
To read the latest IPE Real Assets magazine click here.
